Analytical Data
-
Gene name
FSH beta
- Application
-
Alternative Names
FSH-B; Follitropin Subunit Beta
-
Species
Human
-
Source
HEK293
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
P01225
-
Expression Region
Asn19~Glu129
-
Protein Length
Partial
-
Molecular Weight
22kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Follicle-stimulating hormone (FSH) is a critical glycoprotein hormone involved in the regulation of reproductive processes in both males and females. It is synthesized in the anterior pituitary gland and plays a pivotal role in folliculogenesis in females and spermatogenesis in males. The hormone consists of two subunits, alpha and beta, with the beta subunit (FSHβ) being crucial for its biological activity and specificity. Research on recombinant FSHβ protein has gained significant attention due to its potential applications in reproductive health, infertility treatments, and assisted reproductive technologies. Advances in biotechnology enable the production of recombinant FSHβ, allowing for high purity and bioactivity, ultimately leading to improved clinical outcomes. Studies have shown that recombinant FSHβ can effectively stimulate ovarian stimulation protocols, enhance egg quality, and optimize in vitro fertilization (IVF) success rates. Additionally, this research explores the molecular mechanisms underlying FSH signaling pathways and their implications in various reproductive disorders. As a result, the development and characterization of recombinant FSHβ protein not only contribute to our understanding of hormonal regulation in reproduction but also pave the way for innovative therapeutic approaches in managing infertility and other reproductive health issues.
